tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Kymera Therapeutics initiated with an Outperform at RBC Capital
PremiumThe FlyKymera Therapeutics initiated with an Outperform at RBC Capital
13d ago
Kymera Therapeutics Announces New Chief Legal Officer
Premium
Company Announcements
Kymera Therapeutics Announces New Chief Legal Officer
26d ago
Kymera Therapeutics appoints Adams as Chief Legal Officer, Corporate Secretary
Premium
The Fly
Kymera Therapeutics appoints Adams as Chief Legal Officer, Corporate Secretary
26d ago
Kymera Therapeutics: Strategic Advancements and Financial Strength Drive Buy Rating
PremiumRatingsKymera Therapeutics: Strategic Advancements and Financial Strength Drive Buy Rating
2M ago
Kymera Therapeutics: Promising Developments and Strong Financial Position Support Buy Rating
Premium
Ratings
Kymera Therapeutics: Promising Developments and Strong Financial Position Support Buy Rating
2M ago
Kymera Therapeutics: Promising KT-621 Progress and Strong Financial Position Justify Buy Rating
Premium
Ratings
Kymera Therapeutics: Promising KT-621 Progress and Strong Financial Position Justify Buy Rating
2M ago
Kymera Therapeutics transferred with Buy rating at B. Riley
PremiumThe FlyKymera Therapeutics transferred with Buy rating at B. Riley
2M ago
Is KYMR a Buy, Before Earnings?
Premium
Pre-Earnings
Is KYMR a Buy, Before Earnings?
2M ago
Kymera Therapeutics initialed with Early-Stage Biotech at Goldman Sachs
Premium
The Fly
Kymera Therapeutics initialed with Early-Stage Biotech at Goldman Sachs
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100